Dr. Duic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
120 Mineola Blvd
Ste 500
Mineola, NY 11501Phone+1 516-663-9500
Education & Training
Johns Hopkins UniversityResidency, Emergency Medicine, 2003 - 2006
University of California Davis HealthResidency, Neurological Surgery, 1998 - 2001- University of California Davis HealthInternship, Transitional Year, 1997 - 1998
New York University School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1999 - Present
NY State Medical License 2007 - 2024
MD State Medical License 2007 - 2008
Clinical Trials
Publications & Presentations
PubMed
- 1212 citationsPhase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent GlioblastomaTeri N. Kreisl, Lyndon Kim, Kraig Moore, Paul Duic, Cheryl Royce
Journal of Clinical Oncology. 2009-02-10 - 81 citationsPhase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomasFabio M. Iwamoto, Teri N. Kreisl, Lyndon Kim, J. Paul Duic, John A. Butman
Cancer. 2010-04-01 - 195 citationsFirst results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim
Journal of Translational Medicine. 2018-05-29
Committees
- Vice Chair, IRB
Professional Memberships
- Society for NeuroOncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
